A Journey Through Diagnostically Challenging Areas in Gynecologic Pathology Updated with New Cases 2019 (CME VIDEOS)

Course Description

The World Health Organization (WHO) has incorporated new, significant developments in various areas of diagnostic gynecologic pathology into its 2014 WHO Classification of Tumours of Female Reproductive Organs. This publication serves as a systemic educational tool for practicing pathologists to adopt new disease classifications and related diagnostic criteria, a guide to clinical management of patients and a disease framework for further investigations. This course parallels and reflects WHO updates and encompasses a broad review of diagnostically challenging areas in gynecologic pathology.

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:

Recognize new diagnostic criteria and disease classifications in gynecological pathology
Apply morphologic and immuno-histochemical criteria for differential diagnoses
Recognize uncommon/unusual gynecologic disease entities and their diagnostic criteria
Learn the clinical implication when applying new diagnostic knowledge in gynecological pathology

Continuing Medical Education and Continuing Certification
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 11.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) and Lifelong Learning (Part II) credit for the purpose of meeting the ABPath requirements for Continuing Certification (CC). Registrants must take and pass the post-test in order to claim SAMs credit.
Physicians can earn a maximum of 11.75 SAM/Part II credit hours.

Disclosures
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty reported no relevant financial relationships: Natalia Buza, MD, Pei Hui, MD, PhD, Teri Longacre, MD, Jennifer Stall, MD, and Robert Young, MD
The following IM Coordinator who planned and reviewed content for this activity reported no relevant financial relationships: Charles Matthew Quick, MD
USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

Topics/Speaker:
Gestational Trophoblastic Disease
Mesenchymal Tumor in GYN Tract
Ovarian Tumors Based on the Robert E. Scully Collection
Pathology of Cervix, Vagina and Vulva
Uterine Epithelial Neoplasms
Original release date: December 5, 2019
Access to this course expires on:  September 27, 2022

]